Z96.65 Z96.64
Conditions
Interventions
Group 1: The survey asks for individual characteristics of the stakeholder group of patients with end stage hip or knee osteoarthritis and and to rate the importance of the items in the core domains s
Sponsors
Brandenburgische Technische Universität Cottbus-Senftenberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: To be involved in the patient group (group A), participants must have end stage osteoarthritis refractory to medical and other nonsurgical treatments, who are candidates for interventions such as elective TJR. For involvement in the physiotherapist group (group B), participants must be physiotherapist with at least three years of working experience in either the management of TJR patients or research involving TJR patients. In the orthopedic surgeons group (group C), participants will be included if they state at least three years of experience in hip or knee TJR surgery or research including TJR patients.
Exclusion criteria
Exclusion criteria: Participants of group A, B or C will be excluded, if: 1. They do not fill out at least 80 percent of the survey. 2. They are not identifiable as members of one of the three groups. Participants of group A) will be excluded, if: 1. They have a Knee or Hip TJR due to an accident or non-degenerative illness. 2. If they currently have a major complication after knee or hip TJR. Participants of group B) and C) will be excluded, if: 1. They are not familiar with the management or research in TJR patients. 2. They do not have at least three years of work experience.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The overall aim is to determine whether there exists consensus within the stakeholder groups. Therefore, the draft of core outcome domains from the related OMERACT group will be given to Subgroups of orthopedic surgeons, physiotherapists and patients with endstage degenerative osteoarthritis. Those subgroups will rate the different core outcome domains in respect to their relevance for patients with endstage degenerative osteoarthritis of the hip and the knee on a Likert-scale 1-9. The results will be transferred to the OMERACT group which controlls the answered surveys. They check accordance in the groups themselves and between the different stakeholder groups. If all groups rated a core outcome domain in accordance to each other, the core outcome domain will be used as a mandatory outcome domain for upcoming studies from then on. If results differ in or across groups, those discrepancies will be presented in the related groups at the annual OMERACT meeting. There, the issues will be discussed and a position statement will be formulated. The remaining core outcome domains will be implemented in another survey round in the single stakeholder groups. This process will be continued until all discrepancies in and across groups are solved. | — |
Countries
Germany
Contacts
Public ContactRobert Prill
Brandenburgische Technische Universität Cottbus-Senftenberg
Outcome results
None listed